Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application
Jinfeng Shi, Jiaxin Li, Ziyi Xu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1
H. Y. Xu, Hongfang Zhao, Chunyong Ding, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 97
Tumor-targeted exosomes for delivery of anticancer drugs
Rajeswari Raguraman, Dhaval Bhavsar, Dongin Kim, et al.
Cancer Letters (2023) Vol. 558, pp. 216093-216093
Open Access | Times Cited: 49
Biocompatible chlorocoumarins from harmful chlorophenols, their synthesis and biomedicinal evaluation
Yasser Fakri Mustafa
Journal of Molecular Structure (2024) Vol. 1309, pp. 138193-138193
Closed Access | Times Cited: 19
Recent advances in drug delivery of celastrol for enhancing efficiency and reducing the toxicity
Yuan Sun, Chengen Wang, Xiaoguang Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 16
4-Chloroskimmetine-based derivatives as potential anticancer and antibacterial prospects: Their synthesis and in vitro inspections
Yasser Fakri Mustafa
Results in Chemistry (2024) Vol. 7, pp. 101511-101511
Open Access | Times Cited: 16
Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics
David B. Neale, Jonathan C. Morris, Nicole M. Verrills, et al.
Pharmacology & Therapeutics (2025), pp. 108834-108834
Closed Access | Times Cited: 2
Celastrol in cancer therapy: Recent developments, challenges and prospects
Hannah Ying Lim, Pei Shi Ong, Lingzhi Wang, et al.
Cancer Letters (2021) Vol. 521, pp. 252-267
Closed Access | Times Cited: 82
Celastrol in metabolic diseases: Progress and application prospects
Shaohua Xu, Yaqian Feng, Weishen He, et al.
Pharmacological Research (2021) Vol. 167, pp. 105572-105572
Closed Access | Times Cited: 79
Hollow Nanomaterials in Advanced Drug Delivery Systems: From Single‐ to Multiple Shells
Li Zhao, Ke Xu, Linlin Qin, et al.
Advanced Materials (2022) Vol. 35, Iss. 12
Closed Access | Times Cited: 67
Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence
Zohra Nausheen Nizami, Hanan E. Aburawi, Abdelhabib Semlali, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1159-1159
Open Access | Times Cited: 31
Niosome as a promising tool for increasing the effectiveness of anti-inflammatory compounds.
Mohammad Saleh Fadaei, Mohammad Reza Fadaei, Amiremad Kheirieh, et al.
PubMed (2024) Vol. 23, pp. 212-263
Closed Access | Times Cited: 13
Synthesis and evaluation of linearly fused thiadiazolocoumarins as prospects with broad-spectrum bioactivity
Rana Naeem Jibroo, Yasser Fakri Mustafa, Wejdan Al-Shakarchi
Results in Chemistry (2024) Vol. 7, pp. 101494-101494
Open Access | Times Cited: 12
Degradation‐Based Protein Profiling: A Case Study of Celastrol
Zhihao Ni, Yi Shi, Qianlong Liu, et al.
Advanced Science (2024) Vol. 11, Iss. 25
Open Access | Times Cited: 10
Nanoparticle‐Based Drug Delivery Platform for Simultaneous Administration of Phytochemicals and Chemotherapeutics: Emerging Trends in Cancer Management
S.M. Kawish, Shwetakshi Sharma, Priya Gupta, et al.
Particle & Particle Systems Characterization (2024)
Open Access | Times Cited: 9
Prodrug-inspired adenosine triphosphate–activatable celastrol-Fe(III) chelate for cancer therapy
Hanrong Li, Yifan Li, Lingpu Zhang, et al.
Science Advances (2024) Vol. 10, Iss. 28
Open Access | Times Cited: 9
Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via DDIT3 and ATF3 Up-Regulation and RRM2 and MCM4 Down-Regulation
Mаhmoud Youns, Momen Askoura, Hisham A. Abbas, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 3849-3860
Open Access | Times Cited: 47
Advanced Computational Methodologies Used in the Discovery of New Natural Anticancer Compounds
Vivek P. Chavda, Yavuz Nuri Ertaş, Vinayak Walhekar, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 42
Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors
Yirivinti Hayagreeva Dinakar, Hitesh Kumar, Shyam Lal Mudavath, et al.
Life Sciences (2022) Vol. 309, pp. 120996-120996
Closed Access | Times Cited: 37
Engineering neoantigen vaccines to improve cancer personalized immunotherapy
Zaoqu Liu, Jinxiang Lv, Qin Dang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5607-5623
Open Access | Times Cited: 28
Self-delivery biomedicine for enhanced photodynamic therapy by feedback promotion of tumor autophagy
Shaoyi Chen, Linping Zhao, Zu‐Xiao Chen, et al.
Acta Biomaterialia (2023) Vol. 158, pp. 599-610
Closed Access | Times Cited: 20
Natural products modulate NLRP3 in ulcerative colitis
Jia-Chen Xue, Shuo Yuan, Xiao-Ting Hou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Mechanistic engineering of celastrol liposomes induces ferroptosis and apoptosis by directly targeting VDAC2 in hepatocellular carcinoma
Piao Luo, Qian Zhang, Shuo Shen, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100874-100874
Open Access | Times Cited: 18
Dual role of PRDX1 in redox-regulation and tumorigenesis: Past and future
Xin‐Yuan Guan, Yiyin Ruan, Xiaoxia Che, et al.
Free Radical Biology and Medicine (2023) Vol. 210, pp. 120-129
Closed Access | Times Cited: 17
3-mercaptocoumarins as potential bioactive candidates: From novel synthesis to comparative analysis
Yasser Fakri Mustafa
Journal of Molecular Structure (2024) Vol. 1320, pp. 139657-139657
Closed Access | Times Cited: 7
Enzyme/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating
Jinfeng Shi, Jiahui Zhou, Bo Liu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top